LY4064809

· Scorpion Therapeutics (subsidiary of Eli Lilly and Company)

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LY4064809, covering 2025-09-23 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4064809 in Healthy Adult Participants [Phase 1]